Biofrontera Inc. (BFRI)
NASDAQ · Manufacturing · Pharmaceutical preparations
$1.18−$0.0200 (−1.67%) on the dayAs of the close; data may be delayed.
BFRI price, last 12 months
Key stats
- Previous close
- $1.20
- Open
- $1.20
- Day range
- $1.16 – $1.23
- 52-week range
- $0.5547 – $1.66
- Volume
- 248.1K
- Avg volume (20 days)
- 783K
- Market cap
- $17.5M
Performance
1W−10.6%
1M−22.9%
3M+21.5%
6M+45.7%
YTD+107.0%
1Y+22.9%
vs S&P 500, 1Y+6.2 pts
Technicals and fundamentals
About Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $17.5M